Skip to content

Comparison of LMA-Fastrach and I-gel for Blind Tracheal Intubation.

Comparison of LMA-Fastrach and I-gel for Blind Tracheal Intubation.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01007370
Enrollment
160
Registered
2009-11-04
Start date
2010-03-31
Completion date
2010-05-31
Last updated
2017-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Anesthesia

Keywords

tracheal intubation, supraglottic airway devices

Brief summary

The investigators aim to compare two different types of supraglottic devices for tracheal intubation in patients undergoing elective surgery under general anesthesia. Our hypothesis is that the use of the I-gel supraglottic airway will result in a higher first attempt success rate of blind tracheal intubation.

Detailed description

Supraglottic airway devices such as LMA-Fastrach and I-gel provide patent airways during general anesthesia. The LMA-Fastrach is designed to provide a conduit for blind or fiberoptically guided tracheal intubations. However, the success rate of tracheal intubation on the first attempt through this device varies between 50 and 87%. The I-gel is a newer device for airway management which, with its wide bore, allows direct passage of a tracheal tube. Recent studies suggest that the I-gel is easy to insert and that limited experience is needed before a high success insertion rate is obtained. In this prospective and randomized study, we will evaluate the performance of both devices for tracheal intubation in patients undergoing elective surgery under general anesthesia.

Interventions

PROCEDURETracheal intubation

Tracheal intubation through a supraglottic airway device(LMA-Fastrach).

Sponsors

Centre hospitalier de l'Université de Montréal (CHUM)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age 18 and older * ASA physical status 1-3 * Patients undergoing elective surgery under general anesthesia, requiring endotracheal intubation

Exclusion criteria

* ASA physical status 4-5 * Contraindications to muscle relaxation * Anticipated or known difficult intubation or ventilation * Patients with limited mouth opening (less than 2 cm) * Patients at increased risk of aspiration, or having an history of symptomatic gastroesophageal reflux or hiatal hernia.

Design outcomes

Primary

MeasureTime frame
First attempt success rate of tracheal intubation.After successful insertion of tracheal tube

Secondary

MeasureTime frame
Time needed for successful insertion of a supraglottic device.After insertion
First and total attempt success rate of supraglottic device insertion.After insertion
Total time and number of attempts needed to obtain successful tracheal intubation.After tracheal intubation
Fiberoptic view following the supraglottic device insertion.After insertion of the device

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026